The COVID-19 Pandemic
This page provides educational resources, events, news and products related to the COVID-19 pandemic. Content will cover aspects from diagnostics, therapeutics and prevention, to viral genomics, pathogen-host interactions and the immune response to infection.
The COVID-19 Pandemic – Highlights
The Coronavirus Pandemic
On December 31, 2019, the first cases of a novel coronavirus were identified in Wuhan City, Hubei Province, China. Here, we curate a collection of news and content related to what has become the COVID-19 pandemic.
Fighting the Virus: SARS-CoV-2 Immunity
Download this infographic to learn more about immunity and SARS-CoV-2.
Teach Me in 10 – Engineering a Decoy Receptor for SARS-CoV-2 With Dr Erik Procko, Part II
Dr Erik Procko has been working on engineering a "decoy" receptor for SARS-CoV-2, the virus that has caused the COVID-19 global pandemic. In the second video of this two-part installment, Dr Procko discusses his research in exploring the mutational landscape of ACE2 to further understand the interaction between the receptor and the S protein of SARS-CoV-2.
Deciphering SARS-CoV-2 Transmission With Serology Surveillance
In many countries, diagnostic testing to detect active SARS-CoV-2 infection has played an important role in the management of COVID-19. In this article, we explore how seroprevalence studies, also known as serosurveys, provide a means of understanding community transmission of SARS-CoV-2. We also discuss the challenges of interpreting serological results and identifying people who had mild infections.
New Type of Nanoparticle Can Perform Gene Editing in the Lungs
Researchers have used a new type of nanoparticle to deliver RNA to the lungs in mice. These particles could offer an inhalable treatment for cystic fibrosis and other diseases of the lung in the future.
Can the Chilean Soapbark Tree Change the Way We Make Vaccines?
The medicinal secrets of the Chilean soapbark tree have been laid bare, unlocking a future of more potent, affordable, and sustainably sought vaccines.
Hidden "Super Spreaders" Key to Dengue Fever Risk
A new study suggests that the number of “hidden” infections tied to a place, or cases of infected people who show no symptoms, is the key indicator for dengue risk.
Global Regulators Embrace Collaborative Initiatives
Regulators are increasingly collaborating on a global scale, sharing expertise across regions for mutual benefit. In this article, Piety Rocha examines this upward trend.
Aseptika’s Active+me REMOTE for Cardiac Rehabilitation Funded by Innovate UK
Co-funded by Innovate UK, Aseptika is collaborating with the University of Birmingham, University of York and the National Audit of Cardiac Rehabilitation to study the impact of a hybrid delivery of cardiac rehabilitation.
BioGrad to Open the UK's Second Largest Biobank Facility in Liverpool
BioGrad is to open the UK's second-largest biobank facility in Liverpool, as part of a £7.6m investment into a new headquarters at Wavertree Technology Park.
App Note / Case Study
Distinguishing Oxidative Impurities From Ionizable Lipids Used in LNP Formulations
Lipid nanoparticles (LNPs), comprised of ionizable lipids, are used to deliver oligonucleotides to work as therapeutics or to stimulate the immune system, as in the initial mRNA-based COVID vaccines.